Devyser launches the first IVDR compliant NGS assay for thalassemia and sickle cell disease testing
Devyser, today announced the launch of Devyser Thalassemia v2, the first Next-Generation Sequencing...
Podcast
Podcast | December 6, 2022
This episode is dedicated to the 10-year anniversary of Genomics England's 100,000 Genomes Project hosted by Precision Medicine Forum. It's the second of 4 interviews released this week as a celebration. In this episode, they interviewed two of our colleagues Dan Hauzenberger and Turid Sundin Carlsson about the importance of collaborative work, 'homebrew assays', and a future with preventative healthcare.
You can listen to the episode here --> Precision Medicine Forum Podcast - Episode 16
Devyser, today announced the launch of Devyser Thalassemia v2, the first Next-Generation Sequencing...
Read More
Devyser Diagnostics AB (publ), a Swedish molecular diagnostics company, today announces that it has...
Read More
Devyser today announced that it entered a strategic agreement with Illumina, a global leader in DNA...
Read More
Devyser is proud to announce that the company has been awarded a tender by Oslo University Hospital...
Read More